Influence of enteral formula containing EPA/DHA on inflammation and iron metabolism in tube-fed elderly patients
Not Applicable
- Conditions
- chronic inflammation, abnormal iron metabolism
- Registration Number
- JPRN-UMIN000010990
- Lead Sponsor
- Fukushimura Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients receiving enteral formula containing EPA/DHA. 2)Patients with hepatic, renal, cardiovascular, respiratory and intestinal dysfunction, persistent infection and malignancy. 3)Patients with allergy to milk, soybean and fish oil, which are contained in the enteral formula. 4)Patients judged as inappropriate for the study by the physician in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method